TOPLINE: Antitumor necrosis factor (TNF) therapy alone yields outcomes comparable with those seen with anti-TNF therapy combined with surgery in patients with perianal fistulizing Crohn’s disease (PFCD), according to a meta-analysis. METHODOLOGY: Researchers conducted a systematic review and meta-analysis of 13 studies that included 1251 patients who received combination therapy of surgical intervention and anti-TNF …
Read More
